Biomarker suPAR Predicts Chronic Kidney Disease

A potential new kidney disease biomarker, suPAR, is causing a big stir in the research community. Previous studies have identified the blood protein as a potential cause of Focal Segmental Glomerulosclerosis, or FSGS. Now a multi-institutional study involving scientists from Rush University, Emory University, Massachusetts General Hospital and Harvard Medical…

Continue reading

Share Button

Dr. Richard Glassock Webinar on Evaluating FSGS

Recently Dr. Richard Glassock participated in an interesting webinar for the International Society of Nephrology.  View Dr. Glassock’s webinar to hear him discuss his FSGS axioms, the best approach to evaluate FSGS, and recent research on suPAR as a potential biomarker.  

Continue reading

Share Button

Researchers Discover Cause of FSGS

A team of nephrologists and researchers at University of Miami Miller School of Medicine have discovered a factor in the blood that may be responsible for up to two-thirds of the cases of focal segmental glomerulosclerosis or FSGS. They found that an excess of serum soluble urokinase receptor (suPAR) activates…

Continue reading

Share Button